Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock
- 30 September 1994
- Vol. 6 (5) , 500-503
- https://doi.org/10.1016/1043-4666(94)90077-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.The Journal of Experimental Medicine, 1991
- A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbitsThe FASEB Journal, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.The Journal of Experimental Medicine, 1989
- Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.The Journal of Experimental Medicine, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shockIntensive Care Medicine, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.Journal of Clinical Investigation, 1981
- Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock.Circulation Research, 1980